Ability Inc., through its subsidiaries, provides interception, geolocation, and cyber intelligence products and solutions for security and intelligence agencies, military forces, law enforcement agencies, and homeland security agencies worldwide. It specializes in off-air interception of voice, SMS, and data communication from cellular and satellite communication networks; and deciphering solutions for cellular and satellite communications. The company offers strategic and tactical cellular interception systems for intercepting mobile phone traffic and tracking mobile phone users; and satellite link interception systems, as well as international mobile subscriber identity catchers, advanced CDMA interception systems, in-between interception systems, and ultimate interceptions. It also provides geolocation systems to geographically target mobile phones; cyber solutions that enable the user to extract and view information from mobile phones. Ability Inc. was founded in 1994 and is headquartered in Tel Aviv, Israel....
+See More2018-01-10 08:40:00 Wednesday ET
President Trump considers imposing retaliatory economic sanctions on Chinese products and services in direct response to China's theft and infringement
2018-12-09 08:44:00 Sunday ET
President Trump meets with Chinese President Xi again at the G20 summit in the city of Buenos Aires, Argentina, in late-November 2018. President Donald Trum
2023-04-14 13:32:00 Friday ET
Calomiris and Haber delve into the comparative analysis of bank crises and politics in America, Britain, Canada, Mexico, and Brazil. Charles Calomiris an
2019-06-05 10:34:00 Wednesday ET
Fed Chair Jay Powell suggests that the recent surge in U.S. business debt poses moderate risks to the economy. Many corporate treasuries now carry about 40%
2025-10-08 11:34:00 Wednesday ET
Stock Synopsis: With a new Python program, we use, adapt, apply, and leverage each of the mainstream Gemini Gen AI models to conduct this comprehensive fund
2026-10-31 12:38:00 Saturday ET
Today tech titans and billionaires continue to reshape global pharmaceutical investments for both better healthspan and longer lifespan. We discuss, desc